Boundless Bio Stock Forward View - Relative Strength Index
| BOLD Stock | USD 1.13 0.01 0.89% |
Predicting where Boundless Bio's stock will trade is more achievable when sentiment data complements traditional analysis. This module isolates the sentiment-driven component of price to highlight potential mispricings.
At this point in time, the 14-period RSI for Boundless Bio is 0, signaling extreme oversold conditions. Historically, RSI levels this depressed have preceded relief bounces, though the magnitude and duration vary widely.Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -0.51 | EPS Estimate Current Year -2.38 | EPS Estimate Next Year -1.28 | Wall Street Target Price 4 | EPS Estimate Current Quarter -0.52 |
This view frames how Boundless Bio Common responds to recent headlines and peer activity within its market context.
Boundless Bio after-hype prediction price | $ 1.12 |
The sentiment view is a companion to forecasting, technical studies, analyst estimates, and earnings trends.
Boundless | Build portfolio with Boundless Stock |
Boundless Bio Additional Predictive Modules
Forecasting Boundless Bio's price movement relies on structured analysis of indicator behavior, momentum signatures, and historical volatility patterns. Time-series models tend to perform better when fed clean, stationary data with consistent periodicity.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Boundless Bio Volatility | Backtest Boundless Bio | Information Ratio |
Boundless Bio Trading Date Momentum
| On March 17 2026 Boundless Bio Common was traded for 1.13 at the closing time. The top price for the day was 1.13 and the lowest listed price was 1.12 . There was no trading activity during the period 0.0. Lack of trading volume on March 17, 2026 did not affect price variability. The overall trading delta against the current closing price is -0.88% . |
| Compare Boundless Bio to competition |
Other Forecasting Options for Boundless Bio
For both new and experienced investors in Boundless, the ability to analyze Boundless Bio's price movement is a fundamental investment skill. Price chart noise in Boundless Stock can create false signals and mislead investment decisions.Boundless Bio Related Equities
The following equities are related to Boundless Bio within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Boundless Bio against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Boundless Bio Market Strength Events
Tracking market strength indicators for Boundless Bio helps investors understand the momentum dynamics of the stock in real time. These signals support informed decisions about when to enter or exit positions in Boundless Bio Common for maximum return potential.
Boundless Bio Risk Indicators
Properly assessing Boundless Bio's risk indicators is a prerequisite for building reliable price forecasts. Identifying and quantifying the risks associated with Boundless Bio's allows investors to make better-informed decisions about accepting or hedging their exposure.
| Mean Deviation | 1.71 | |||
| Standard Deviation | 2.52 | |||
| Variance | 6.37 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Boundless Bio
Story coverage around Boundless Bio Common often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Contributor Headline
Latest Perspective From Macroaxis
Boundless Bio Short Properties
A short-interest review of Boundless Bio Common helps investors understand whether skepticism in the market is becoming more influential. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
| Common Stock Shares Outstanding | 22.4 M | |
| Cash And Short Term Investments | 107.6 M |
More Resources for Boundless Stock Analysis
Understanding Boundless Bio Common typically begins with financial statements and long-term trend review. Financial ratios provide a structured lens for assessing Boundless Bio's profitability and growth trends. Below are reports that help frame Boundless Bio Common Stock in context:Cross-verify projections for Boundless Bio using Historical Fundamental Analysis of Boundless Bio. The historical view provides additional context. Boundless Bio currently shows ROE of -46.69%, market cap of 24.85 Million. This analysis of Boundless Bio works best as a complementary layer when evaluating how the security fits in a broader portfolio. The supplemental views below help investors decide how Boundless Bio complements or overlaps with existing portfolio holdings. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Investors evaluate Boundless Bio Common using market value and book value, each describing different facets of the business. Boundless Bio's market capitalization is 24.85 M. A P/B ratio of 0.23 suggests Boundless Bio trades near or below book value. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Boundless Bio differs from its quoted price, since each reflects a different lens. For Boundless Bio, key inputs include a P/B ratio of 0.23, and ROE of -46.69%. Boundless Bio market price reflects the current exchange level formed by active bids and offers.